はじめての方へショーケース価格
  1. 米国企業
  2. ABBOTT LABORATORIES

ABBOTT LABORATORIESABT

時価総額
$1806.2億
PER
31.6倍
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2010年
12月31日		2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net earnings4,626--2,5762,2844,4231,4004772,3683,6874,4957,0716,9335,723
Depreciation1,2071,3951,3649289188718031,0461,1001,0781,1951,4911,2541,277
Amortization of intangible assets1,4171,6491,4207916306015501,9752,1781,9362,1322,0472,0131,966
Investing and financing losses, net-126-142-356-4-6918-86-47-126-184-425-55-215-126
Share-based compensation387383433262246292310406477519546640685644
Share-based compensation387383433262246292310406477519546640685644
Trade receivables395670-3611319517117720719027592438368356
Investing and financing losses, net-126-142-356-4-6918-86-47-126-184-425-55-215-126
Share-based compensation387383433262246292310406477519546640685644
Inventories-14013041715429725798-2495145934934561,413232
Trade receivables395670-3611319517117720719027592438368356
Prepaid expenses and other assets-553-41335-131-30-57-113-109-2313862731275542
Inventories-14013041715429725798-2495145934934561,413232
Trade accounts payable and other liabilities-1,790-134-436-225-742-6526157472201,7661,288420-760
Prepaid expenses and other assets-553-41335-131-30-57-113-109-2313862731275542
Income taxes-212-1,402-1,309-665197957-6991,149-214-545-614-908-383-585
Trade accounts payable and other liabilities-1,790-134-436-225-742-6526157472201,7661,288420-760
Net Cash From Operating Activities---3,3243,6752,9663,2035,5706,3006,1367,90110,5339,5817,261
Income taxes-212-1,402-1,309-665197957-6991,149-214-545-614-908-383-585
Net Cash From Operating Activities---3,3243,6752,9663,2035,5706,3006,1367,90110,5339,5817,261
Acquisitions of property and equipment1,0151,4921,7951,1451,0771,1101,1211,1351,3941,6382,1771,8851,7772,202
Acquisitions of businesses and technologies, net of cash acquired---------17042187-877
Proceeds from business dispositions-----230256,0424848581344840
Purchases of investment securities------------185159
Proceeds from Sale of Other Investments------------15243
Other18-16-3-21-75-52-42-35-48-27-19-26-22-22
Net Cash From (Used in) Investing Activities-12,188---3,929-202406-248-9,618-1,356-1,815-2,215-2,008-1,740-3,133
Proceeds from (Repayments of) Short-Term Debt-204-1,9657842,0861,343-1,281-1,767-1,034-26-2-2044721
Proceeds from Long-Term Debt and Debt Maturing in More than Three Months------------72
Repayments of long-term debt and debt with maturities over 3 months------------7532,498
Purchases of common shares867772,3641,6052,1952,2375221172387184032,2993,7951,227
Proceeds from stock options exercised3289691,850395429314248350271298245255167167
Dividends paid------1,5391,8491,9742,2702,5603,2023,3093,556
Other-----------11---
Net Cash From (Used in) Financing Activities-1,088---6,696-2,742-2,23611,147-5,281-10,391-4,289-2,779-5,494-7,636-7,091
Net Cash From (Used in) Financing Activities-1,088---6,696-2,742-2,23611,147-5,281-10,391-4,289-2,779-5,494-7,636-7,091
Effect of exchange rate changes on cash and cash equivalents---------116-1671-70-122-23
Net Increase (Decrease) in Cash and Cash Equivalents---------5,563162,9782,96183-2,986
Income taxes paid-------5707409309701,9411,8641,475
Interest paid-------917845677549544563662